Hrayr Attarian, MD, professor of neurology, Northwestern Feinberg School of Medicine, shares findings on sleep inequities that have greatly impacted refugees.
A big gap in sleep research can be addressed by focusing on accessible sleep health care for vulnerable populations, says Hrayr Attarian, MD, professor of neurology, Northwestern Feinberg School of Medicine.
These findings were presented at the 2024 SLEEP: American Academy of Sleep Medicine and Sleep Research Society (APSS) Annual Meeting.
This transcript was lightly edited.
Transcript
Can you provide an overview of your presentation on sleep inequities?
Yes, so my presentation was specifically about refugees. There's now a fair amount of data from the 1990s and on, starting with displaced people post the fall of the Soviet Union, and there were inter-ethnic conflicts in different previously Soviet republics. So, the research sort of started there. And then now, the majority of it is in displaced people in the Middle East because of the many conflicts that we've seen over the past 25 years there.
I want to impart to people that they recognize that sleep disturbances are extremely high in this population, they are strongly associated with poor quality of life outcomes, and they may also impact their health. As far as interventions, we have very few because of limited resources, but there are ways by which successful interventions—even in very resource limited settings—can be implemented, as long as we first recognize the prevalence of sleep disorders in this population.
What do you believe are some of the biggest research gaps in understanding sleep health?
The biggest research gaps first of all [are] finding ways to make sleep health accessible to everybody, regardless of the situation and the income level. Also, we have to find ways to address crises that [have] happened. For example, with the Philips CPAP [continuous positive airway pressure] recall. There was a major vacuum, a lot of people's sleep apnea was suffering, and we didn't have any way of knowing what else we could do.
I think we need to be more prepared, because we don't know when something like that may happen [or] when another pandemic may hit. I think that, in my opinion, the biggest gaps are not necessarily in the hardcore research about pathophysiology, but in the delivery of care in to vulnerable populations and for everybody in unusual circumstances.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Zanubrutinib Shows Durable Benefit for High-Risk CLL/SLL at 5 Years in SEQUOIA Trial
June 6th 2025Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and deletion of the 17p chromosome, with progression-free survival similar to patients without high-risk disease characteristics.
Read More
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More